Specifically, it is likely that, on the one hand, PBA inhibits tumor progression in experimental cancer therapeutics through inhibiting HDAC activity, and on the other hand, PBA restores the cellular acetyl-CoA level and potentially promotes cancer cell survival in the nutrient-deprived tumor microenvironment. This evidence concerns the gene HDAC9 and neoplasm.